New Materials Series B Investors & VC Firms
280 firms in this list, with a median first check of $540K. 13 of them lead rounds. Generated from verified public data and updated continuously.
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
8 people
Chalmers Ventures AB
GothenburgPre-Seed–Series B$21.6M
11 people
Cowin Capital Group
ShenzhenSeed–Late Stage
11 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $5M
8 people
Fortune Venture Capital
ShenzhenSeed–Late Stage
11 people
Main Sequence Ventures
EveleighSeed–Series B
11 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
Nysnø Climate Investments
StavangerSeed–Late Stage
11 people
Sambrinvest
CharleroiSeries A–Late Stage
11 people
Sorin Investments
MumbaiSeries A–Series B
11 people
Spiltan Invest
StockholmSeed–Late Stage$1.6M – $8.6M
8 people
Trident Capital
Palo AltoSeed–Late Stage$5M – $35M
8 people
UMC Capital
TaipeiSeed–Late Stage
11 people
VantagePoint Capital Partners
Santa BarbaraSeed–Late Stage$2M – $100M
8 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
XPV Water Partners
TorontoSeries A–Late Stage
11 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
Deep Insight
Tel AvivPre-Seed–Late Stage
4 people
Future Energy Ventures
BerlinSeed–Late Stage$1.1M – $5.4M
7 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
7 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
7 people
Shift4Good
ParisSeries A–Series B$540K – $21.6M
7 people
Starquest Capital
ParisSeed–Series B$1.1M – $10.8M
7 people
Related lists
Series B Investors & VC Firms (2615)Series B Investors & VC Firms in United States (1005)SaaS Series B Investors & VC Firms (750)Enterprise Software Series B Investors & VC Firms (731)New Materials Investors & VC Firms (652)Healthtech Series B Investors & VC Firms (596)New Materials Series A Investors & VC Firms (590)New Materials Seed Investors & VC Firms (560)Fintech Series B Investors & VC Firms (550)Biotech Series B Investors & VC Firms (526)
Data sourced from public filings and firms' own websites — see our methodology.